Sri Sivalingam, MD, discusses how suction-based technologies are improving stone clearance and raising expectations for ureteroscopic stone treatment.
|Videos|October 4, 2021
Dr. Ghanney Simons on the merit of diversity in health care
Author(s)Urology Times staff
"This work isn't for one; it is certainly for all,” says Efe C. Ghanney Simons, MD.
Advertisement
In this video, Efe C. Ghanney Simons, MD, discusses the importance of diversity in the field of urology and several ways in which urologists can restructure their institutions to become more inclusive. Ghanney Simons is a urology resident at University of California, Los Angeles.
Advertisement
Related to this article
Abraham Morgentaler, MD, reviews evidence showing no association between testosterone therapy and prostate cancer risk and explains the saturation model of androgen action.
Mark D. Tyson, II, MD, MPH, reviews emerging bladder-sparing therapies for NMIBC, highlighting cretostimogene data, treatment sequencing, and the need for comparative trials.
An analysis of NRG/RTOG 0815 found Decipher predicted distant metastasis risk and identified patients with greater benefit from short-term ADT.
The AMA issued separate codes for subfascial and subcutaneous implantation of a tibial neuromodulation device.
John P. Sfakianos, MD, discusses how ctDNA can be optimally integrated into bladder cancer clinical trials.
Brian Mazzarella, MD, discusses the landscape for intermediate-risk prostate cancer and early VAPOR 2 findings on water vapor ablation.
Armine K. Smith, MD, discusses the importance of integrating sexual health into bladder cancer care, including proactive counseling, preservation strategies, and multidisciplinary support.
Advertisement
Advertisement